कंपनी का अवलोकन
SenesTech, Inc. is a specialized entity dedicated to the development and commercialization of technologies designed for the management of animal pest populations via fertility control mechanisms. The firm operates within the Basic Materials sector, specifically functioning in the Specialty Chemicals industry, where it formulates and distributes chemical solutions for pest mitigation. This enterprise maintains a relatively small operational footprint, employing a workforce of 23 individuals to execute its strategic initiatives. The company currently holds a market capitalization of $8.49M and reports trailing twelve-month revenues of $2.22M. These valuation and revenue figures suggest that SenesTech operates as a micro-cap entity with limited market penetration relative to its peers in the specialty chemicals space. The modest scale indicated by the market cap and revenue implies that the business is likely in a growth or development phase rather than a mature profit-generating stage.
वित्तीय स्वास्थ्य
SenesTech, Inc. reported trailing twelve-month revenues of $2.22M, yet generated a net income of $-6,383,000, revealing a severe disconnect between top-line sales and bottom-line profitability. The company's EBITDA stands at $-6,370,000, which indicates that operating expenses significantly exceed gross revenue, pointing to a cost structure that is currently unsustainable under current production volumes. Free cash flow for the period was $-3,711,375, demonstrating that the company is burning through cash reserves to fund its operations and research activities. The gross margin sits at 62.5%, which reflects a favorable pricing power or low cost of goods sold relative to sales, while the operating margin is critically low at -446.8%, suggesting high overhead or R&D expenditures that are not yet covered by revenue. Furthermore, the profit margin is -287.4%, confirming that the company is incurring substantial losses on every dollar of revenue generated. On the balance sheet, the firm holds $8.57M in cash against $2.68M in debt, resulting in a debt-to-equity ratio of 27.98. Despite the high debt-to-equity figure, the substantial cash buffer suggests the company has significant liquidity to manage its obligations without immediate refinancing risk. The current ratio is an exceptionally high 12.61, indicating that the company possesses more than twelve times the current assets required to cover its short-term liabilities, reflecting strong short-term liquidity. However, the return on equity is -105.7% and the return on assets is -50.4%, metrics that reveal that management has not yet been effective in generating positive returns on the capital invested in the business.
मूल्यांकन आकलन
The trailing P/E ratio is listed as N/A due to the negative earnings, while the forward P/E is reported as -0.36, implying that the market anticipates a recovery in earnings or that valuation models are currently skewed by the company's loss-making status. The price-to-book ratio stands at 0.87, which indicates that the market is currently valuing the company at less than its book value, suggesting a discount rather than a premium over the tangible assets. The price-to-sales ratio is 3.82, and the EV/EBITDA is -0.41, both of which are alternative metrics used to value companies with negative earnings, highlighting that the market is pricing the stock based on revenue multiples and asset backing rather than profitability. SenesTech, Inc. shares have traded between a 52-week high of $6.24 and a 52-week low of $1.31, establishing a wide volatility range for the stock. The beta value is 0.25, which signifies that the stock price is only 25% as volatile as the broader market, indicating a low correlation with general market fluctuations. This low beta suggests that the stock price is driven primarily by company-specific factors such as product development milestones or regulatory approvals rather than macroeconomic trends.
Growth & Income
The revenue growth year-over-year stands at -16.0%, while the earnings growth is listed as N/A due to the company's loss-making status, implying that the firm is currently contracting in terms of sales volume. Since the company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it is classified as a non-dividend payer that reinvests all available capital back into the business rather than distributing income to shareholders. The absence of a dividend payout ratio renders the question of sustainability moot, as the company retains all earnings to fund its ongoing operations and technological development efforts. The overall growth and income profile for SenesTech, Inc. is characterized by negative revenue expansion and a lack of current income distribution, reflecting a strategy focused on long-term product commercialization rather than short-term shareholder returns.